Neurohypophyseal Diabetes InsipidusSymptoms, Doctors, Treatments, Advances & More
Learn About Neurohypophyseal Diabetes Insipidus
Arginine vasopressin deficiency (previously called neurohypophyseal diabetes insipidus) is a disorder of water balance. The body normally balances fluid intake by releasing fluid in urine. However, people with arginine vasopressin deficiency produce an excessive amount of urine (polyuria), which depletes the amount of water in the body. This water loss also leads to excessive thirst (polydipsia).
The familial form of arginine vasopressin deficiency is caused by variants (also called mutations) in the AVP gene. This gene provides instructions for making a hormone called arginine vasopressin (AVP), which is sometimes also called antidiuretic hormone (ADH). This hormone, which is produced and stored in the brain, helps control the body's water balance.
Arginine vasopressin deficiency occurs in approximately 1 in 25,000 individuals. The acquired form is much more common than the familial form.
Familial arginine vasopressin deficiency is almost always inherited in an autosomal dominant pattern, which means that one copy of the altered AVP gene in each cell is sufficient to cause the disorder.
Reading Hospital Endocrinology & Diabetes Center Wyomissing
Ilan Gabriely is an Internal Medicine specialist and an Endocrinologist practicing medicine in Wyomissing, Pennsylvania. Dr. Gabriely is rated as a Distinguished provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Hyperparathyroidism, Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Gabriely is board certified in American Board Of Internal Medicine.
Diabetes And Endocrinology Center At Specialty Services Pavilion
Andjela Drincic is an Endocrinologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 36 years. Dr. Drincic is rated as an Advanced provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Pituitary Tumor, and Hypogonadism.
Tower Health Medical Group Internal Medicine - Wyomissing 1st Floor
Tatyana Erlikh is a primary care provider, practicing in Internal Medicine in Wyomissing, Pennsylvania. Dr. Erlikh is rated as an Advanced provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Psoriasis, Psoriatic Arthritis, Familial Hypertension, and Hypertension. Dr. Erlikh is board certified in American Board Of Internal Medicine.
Summary: The aim of this study is to evaluate whether a new test using mannitol infusion can diagnose the cause of polyuria-polydipsia syndrome as accurately as the current standard test (hypertonic saline infusion) and to compare which test patients prefer. The goal is to identify a simpler and more patient-friendly diagnostic approach.
Summary: An open-labeled, interventional pilot trial, 10 youth with AVP-D and 10 PD matched for age, sex, and BMI will be recruited from Pediatric Endocrinology and Neuroendocrinology at Massachusetts General Hospital and in the community. This study tests the hypothesis that oral estrogen/progestin will stimulate endogenous oxytocin release in control subjects. Eligible participants will receive two table...
Published Date: July 19, 2024
Published By: National Institutes of Health